Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
96.72
+4.84 (5.27%)
At close: Jun 11, 2026, 4:00 PM EDT
96.80
+0.08 (0.08%)
After-hours: Jun 11, 2026, 7:44 PM EDT
Insmed Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 582.19 | 510.45 | 555.03 | 482.37 | 1,074 | 716.78 |
Short-Term Investments | 641.33 | 919.6 | 878.8 | 298.07 | 74.24 | - |
Cash & Short-Term Investments | 1,224 | 1,430 | 1,434 | 780.45 | 1,148 | 716.78 |
Cash Growth | 2.01% | -0.26% | 83.72% | -32.03% | 60.20% | 34.54% |
Accounts Receivable | 178.56 | 140.86 | 52.01 | 41.19 | 29.71 | 24.35 |
Inventory | 132.91 | 132.07 | 98.58 | 83.25 | 69.92 | 67.01 |
Other Current Assets | 78.2 | 91.24 | 37.25 | 24.18 | 25.47 | 28.9 |
Total Current Assets | 1,613 | 1,794 | 1,622 | 929.06 | 1,273 | 837.04 |
Net Property, Plant & Equipment | 131.73 | 139.21 | 115.58 | 104.39 | 102.08 | 95.52 |
Other Intangible Assets | 95.57 | 97.65 | 58.65 | 63.7 | 68.76 | 73.81 |
Goodwill | 136.11 | 136.11 | 136.11 | 136.11 | 136.11 | 136.11 |
Long-Term Investments | - | - | - | - | - | 50.04 |
Other Long-Term Assets | 99.28 | 97.38 | 93.23 | 96.57 | 76.1 | 50.99 |
Total Assets | 2,076 | 2,265 | 2,025 | 1,330 | 1,656 | 1,244 |
Accounts Payable | 352.56 | 456.06 | 285.21 | 214.99 | 182.12 | 125.03 |
Current Portion of Leases | 8.45 | 12.81 | 12.32 | 10.64 | 8.13 | 10.14 |
Total Current Liabilities | 361.01 | 468.87 | 297.53 | 225.63 | 190.24 | 135.17 |
Long-Term Debt | 704.35 | 703.83 | 1,264 | 1,310 | 1,273 | 566.59 |
Long-Term Leases | 29.66 | 32.89 | 33.18 | 38.04 | 44.49 | 35.54 |
Other Long-Term Liabilities | 275.99 | 319.99 | 144.7 | 87.75 | 60.49 | 95.74 |
Total Long-Term Liabilities | 1,010 | 1,057 | 1,442 | 1,436 | 1,378 | 697.87 |
Total Liabilities | 1,371 | 1,526 | 1,740 | 1,662 | 1,568 | 833.04 |
Common Stock | 2.17 | 2.14 | 1.79 | 1.48 | 1.36 | 1.19 |
Additional Paid-in Capital | 6,503 | 6,372 | 4,646 | 3,113 | 2,782 | 2,674 |
Accumulated Other Comprehensive Income | 0 | 1.46 | -2.29 | -0.75 | 0.76 | 0.97 |
Retained Earnings | -5,800 | -5,637 | -4,360 | -3,446 | -2,697 | -2,265 |
Shareholders' Equity | 704.85 | 738.98 | 285.38 | -331.92 | 87.95 | 410.47 |
Total Liabilities & Equity | 2,076 | 2,265 | 2,025 | 1,330 | 1,656 | 1,244 |
Total Debt | 742.46 | 749.54 | 1,310 | 1,359 | 1,326 | 612.27 |
Net Cash (Debt) | 481.05 | 680.51 | 123.88 | -578.58 | -177.6 | 104.51 |
Net Cash Growth | -29.31% | 449.32% | - | - | - | -18.29% |
Net Cash Per Share | 2.32 | 3.42 | 0.76 | -4.12 | -1.44 | 0.93 |
Book Value | 704.85 | 738.98 | 285.38 | -331.92 | 87.95 | 410.47 |
Book Value Per Share | 3.40 | 3.71 | 1.74 | -2.36 | 0.71 | 3.66 |
Tangible Book Value | 473.17 | 505.22 | 90.62 | -531.74 | -116.92 | 200.55 |
Tangible Book Value Per Share | 2.28 | 2.54 | 0.55 | -3.79 | -0.95 | 1.79 |